How does MASLD link to HFpEF?
Our data point to mitochondrial energy metabolism and kidney-related metabolites as key connections—and potential biomarkers.
Full text: https://t.co/trPPWxm1xf
@SvatiShah@CindyMoylan_MD
🧪 How do everyday environmental exposures shape liver cancer risk?
Our review unpacks what’s known, what’s uncertain, and where research is headed.
📄 Ubiquitous Environmental Exposures and Risk of Hepatocellular Carcinoma: A Narrative Review
https://t.co/dDrrknNlz8
Check out our manuscript in @metabolomics!
🔷Aim: find plasma oxylipins associated w/advanced fibrosis in people with HIV + HCV
🔷Model = AST + 7 oxylipins, AUC 0.93!
🔷Role of oxidative stress?
https://t.co/ok2JXjV8RV
@HowardTLeeMD@snaggie1
In @JIDJournal, @KWegermann and colleagues aim to discover lipid metabolite signatures for persons with HIV (PWH), PWH with HCV coinfection, and individuals with metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD, MASH). https://t.co/h3gQyTkAFa
It was 🤩 ! Catch the next 2 AASLD Academic Debates which will be just as awesome:
🔷 Sunday 10am: Terlipressin for pts who are not LT candidates
🔷 Monday 10am: GLP1RA vs bariatric surgery for adolescent MASLD
@LizzieAbyMD
Sad to hear of Dr. Harrison’s passing. Had the honor of introducing him as emcee for Academic Debates at TLM 2023. He was an entertaining and gracious presence. Here he is laying down the law with esteemed judges @Mayo_liverdoc @nagachalasani @RotonyaC
Check out our article:
🔷 53 metabolites (lipids, cysteine) associate with HFpEF in patients with biopsy-proven MASLD
@Duke_GI_@CindyMoylan_MD@FudimMarat@Mayo_liverdoc
Journal of the American Heart Association https://t.co/Qr4xnky4wz
Stoked to hear super⭐️ Dr. Sachi Oshima of @IMResidencyDuke present her work on consent for HCV NAT+ organs today! 4:30pm, Room 4, #ATC2023SanDiego, be there! @Duke_GI_